fingolimod hydrochloride has been researched along with Uveitis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butzkueven, H; Hall, AJ; Lim, LL; Lo, TC; Pimentel, RS; Silva, DG | 1 |
| Collins, W; Francis, G; Jager, RD; Jampol, LM; Reder, AT; Tang, D; Zarbin, MA; Zhang, X | 1 |
| Francis, CE | 1 |
| Copland, DA; Dick, AD; Nicholson, LB; Raveney, BJ | 1 |
| Belfort, R; Bueno, V; Commodaro, AG; Rizzo, LV | 1 |
| Anderson, K; Brinkmann, V; Copland, DA; Dick, AD; Liu, J; Nicholson, LB; Schewitz-Bowers, LP | 1 |
| Hikita, N; Ikeda, E; Kurose, S; Mochizuki, M; Tokiwa, M | 1 |
2 review(s) available for fingolimod hydrochloride and Uveitis
| Article | Year |
|---|---|
Visual issues in multiple sclerosis.
Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis; Neuromyelitis Optica; Nystagmus, Pathologic; Ocular Motility Disorders; Optic Neuritis; Prognosis; Propylene Glycols; Sphingosine; Uveitis | 2013 |
Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation.
Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Fingolimod Hydrochloride; Humans; Immunologic Factors; Immunomodulation; Inflammation Mediators; Propylene Glycols; Sphingosine; Uveitis | 2011 |
2 trial(s) available for fingolimod hydrochloride and Uveitis
| Article | Year |
|---|---|
Uveitis in Patients with Multiple Sclerosis in Clinical Trials of Fingolimod: Incidence, Prevalence, and Impact on Disease Course.
Topics: Adult; Disease Progression; Double-Blind Method; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Multiple Sclerosis; Prevalence; Recurrence; Treatment Outcome; Uveitis | 2019 |
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
Topics: Adolescent; Adult; Double-Blind Method; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Immunosuppressive Agents; Macular Edema; Male; Middle Aged; Multiple Sclerosis; Ophthalmoscopy; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2013 |
3 other study(ies) available for fingolimod hydrochloride and Uveitis
| Article | Year |
|---|---|
Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease.
Topics: Administration, Oral; Animals; Autoimmune Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergency Treatment; Female; Fingolimod Hydrochloride; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Propylene Glycols; Random Allocation; Reference Values; Retinitis; Sensitivity and Specificity; Sphingosine; Treatment Outcome; Uveitis | 2008 |
Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier.
Topics: Animals; Apoptosis; Autoimmune Diseases; Blood-Retinal Barrier; Dose-Response Relationship, Drug; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Mice; Microvessels; Permeability; Propylene Glycols; Retinitis; Sphingosine; Uveitis | 2012 |
Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
Topics: Animals; Antibodies; Arrestin; Autoimmune Diseases; Blood Cell Count; Body Weight; Chi-Square Distribution; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Propylene Glycols; Rats; Rats, Inbred Lew; Retinitis; Sphingosine; Statistics, Nonparametric; T-Lymphocytes; Uveitis | 2000 |